U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
USPH on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
15.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
16M
Holdings value
$1.36B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
242
Number of buys
123
Number of sells
-112
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.2% $169M 2.16M BlackRock, Inc. 30 Jun 2025
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 9.8% +60.7% $118M $43.7M 1.49M +58.9% Kayne Anderson Rudnick Investment Management, LLC 30 Jun 2025
MORGAN STANLEY 5.9% $60M 890K Morgan Stanley 31 Dec 2024
Copeland Capital Management, LLC 5.54% -5.17% $71.7M $14.2M 844K +24.7% Copeland Capital Management, LLC 30 Sep 2025

Institutional Holders of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 16M $1.36B +$38.8M $84.95 242
2025 Q2 15.6M $1.22B +$28.8M $78.20 237
2025 Q1 15.3M $1.11B -$19.8M $72.36 252
2024 Q4 15.6M $1.38B +$12.2M $88.71 254
2024 Q3 15.4M $1.31B +$18.4M $84.63 254
2024 Q2 15.2M $1.4B -$59.2M $92.42 240
2024 Q1 15.6M $1.76B +$17.9M $112.87 234
2023 Q4 15.4M $1.44B +$3.87M $93.14 211
2023 Q3 15.4M $1.41B +$4.04M $91.73 216
2023 Q2 15.2M $1.85B +$187M $121.39 210
2023 Q1 13.7M $1.34B +$28.8M $97.91 195
2022 Q4 13.4M $1.09B +$71.7M $81.03 194
2022 Q3 13.1M $998M -$72.7M $76.02 189
2022 Q2 13M $1.42B +$34.9M $109.20 203
2022 Q1 12.8M $1.27B +$8.9M $99.45 203
2021 Q4 12.7M $1.22B -$20.8M $95.55 205
2021 Q3 12.7M $1.4B -$3.11M $110.60 203
2021 Q2 12.7M $1.47B +$13.6M $115.87 213
2021 Q1 12.6M $1.31B -$14.3M $104.10 206
2020 Q4 12.8M $1.54B -$22.8M $120.25 197
2020 Q3 13M $1.13B -$46.2M $86.88 176
2020 Q2 13.5M $1.09B +$19.4M $81.02 180
2020 Q1 13.4M $921M +$19.5M $69.00 190
2019 Q4 12.9M $1.48B -$44.7M $114.35 207
2019 Q3 13.3M $1.73B -$2.3M $130.55 214
2019 Q2 13.3M $1.63B +$8.08M $122.57 208
2019 Q1 13.3M $1.4B +$22.8M $105.03 213
2018 Q4 13.1M $1.34B +$40.8M $102.35 191
2018 Q3 12.6M $1.5B +$23M $118.60 190
2018 Q2 12.5M $1.2B +$26.9M $96.00 181
2018 Q1 12.2M $993M +$23.4M $81.30 169
2017 Q4 11.9M $862M +$7.26M $72.20 162
2017 Q3 11.9M $729M -$8.51M $61.45 164
2017 Q2 11.9M $722M -$6.82M $60.40 170
2017 Q1 12.1M $789M +$109M $65.30 175
2016 Q4 12.1M $848M +$31.7M $70.20 171
2016 Q3 11.7M $734M -$2.16M $62.70 171
2016 Q2 11.7M $706M -$624K $60.21 164
2016 Q1 11.8M $587M -$27.6M $49.73 148
2015 Q4 12.3M $660M +$34.8M $53.68 140
2015 Q3 11.7M $528M +$6.4M $44.89 131
2015 Q2 11.6M $633M +$15.2M $54.76 127
2015 Q1 11.3M $539M +$6.55M $47.50 128
2014 Q4 11.2M $472M +$1.82M $41.96 124
2014 Q3 11.2M $397M +$5.11M $35.39 111
2014 Q2 11.1M $379M +$217K $34.19 106
2014 Q1 11.1M $382M +$4.07M $34.57 105